fda glp-1 warning news november 2025 Ozempic Lawsuits: Possible Compensation For Damages FDA warns telehealth companies over
Description
A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults
Oncology dominates the hiring
Dulaglutide is a long-acting GLP-1 receptor agonist used for type 2 diabetes and weight management
Importantly, large-scale randomized trials, meta-analyses, and observational studies suggest that GLP-1RAs do not significantly increase AKI risk and may even confer renal benefits in high-risk populations
By reducing appetite and enhancing blood sugar control, this dual-action therapy helps you achieve sustainable results while supporting overall wellness.
Discover how GLP-1 drugs like Ozempic, initially for diabetes and weight loss, show promise in reducing alcohol cravings.
